The Analyst Landscape: 4 Takes On Merit Medical Systems
Portfolio Pulse from Benzinga Insights
Merit Medical Systems (NASDAQ:MMSI) has received varied analyst ratings over the past three months, with 3 bullish and 1 somewhat bullish out of 4 total ratings. The average 12-month price target is $93.25, with a high of $100.00 and a low of $81.00, reflecting a 4.78% increase from the previous target of $89.00. Analysts from Canaccord Genuity, Barrington Research, and Needham have updated their ratings and price targets, indicating a positive outlook on the company's performance. Merit Medical Systems specializes in medical equipment for interventional procedures and has shown strong financial indicators such as revenue growth, net margin, ROE, ROA, and a healthy debt-to-equity ratio.
December 21, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Merit Medical Systems has received positive analyst ratings and an increased average price target, indicating a bullish sentiment. The company's strong financial performance and growth prospects may positively influence its stock price in the short term.
The positive analyst ratings and raised price targets suggest that analysts are optimistic about Merit Medical Systems' future performance. This, combined with the company's strong financial indicators such as revenue growth and profitability, is likely to be viewed favorably by investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100